Ultragenyx Pharmaceutical (UP0.F) Q3 2024 Earnings

1AugConfirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-2.1
-1.87
-1.64
-1.41

Details

Expected EPS
-1.53903426325
Actual EPS
-1.40866
Surprise EPS
0.13
Surprise Percent
+8.47%

Description

Ultragenyx Pharmaceutical (UP0.F) has reported earnings of -1.40866 per share for Q3 2024.

0 Comments

Share your thoughts